CDC’s Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury

Published: 10/16/2019

  • Centers for Disease Control and Prevention
Relevant To:
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care,
  • Rural Health Clinics

The U.S. Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), state and local health departments, and public health and clinical partners continue to investigate the multistate outbreak of lung injury associated with the use of electronic cigarette (e-cigarette) or vaping products. In late August, CDC released recommendations for health care providers regarding e-cigarette or vaping product use associated lung injury (EVALI) based on limited data from the fir

Sign Up for Free Trial